Synthesis and characterization of thiocarbonato-linked platinum(<scp>iv</scp>) complexes-Reference-Cited by-同舟云学术

Synthesis and characterization of thiocarbonato-linked platinum(iv) complexes

Published:2022 Issue:14 Volume:51 Page:5567-5576
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Barth Marie-Christin¹^ORCID,Lange Stefanie²,Häfner Norman²^ORCID,Ueberschaar Nico³^ORCID,Görls Helmar¹,Runnebaum Ingo B.²,Weigand Wolfgang¹^ORCID

Affiliation:

1. Department of Inorganic and Analytical Chemistry, Friedrich Schiller University Jena, Humboldtstrasse 8, 07743 Jena, Germany

2. Department of Gynecology and Reproduction Medicine, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany

3. Mass Spectrometry Platform, Friedrich Schiller University Jena, Humboldtstrasse 8, 07743 Jena, Germany

Abstract

Novel platinum(iv) complexes with thiocarbonate linkage were synthesized and their cytotoxic activity against ovarian carcinoma cell lines was investigated. Insights into the reaction with ascorbic acid were provided by UHPLC-HRMS.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D2DT00318J

Reference88 articles.

1. Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men

2. Expanding the Arsenal of Pt IV Anticancer Agents: Multi‐action Pt IV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group

3. Oxaliplatin: a review of approved uses

4. The side effects of platinum-based chemotherapy drugs: a review for chemists

5. The rediscovery of platinum-based cancer therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02

2. Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation;Dalton Transactions;2024

3. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action;Успехи химии;2023-10

4. Strategy to Regulate the Stability and Reduction Rate of Oxaliplatin-Based Pt(IV) Complexes: Cocrystallization;Crystal Growth & Design;2023-08-24

5. An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies;Inorganica Chimica Acta;2023-04